PCV6 ESTIMATING THE INCREMENTAL BENEFIT ON FINAL OUTCOMES OF ROSUVASTATIN 40 MG OVER 20 MG IN THE TREATMENT OF PATIENTS WITH HYPERCHOLESTEROLAEMIA BASED ON A META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS
SL Kingslake, SJ EdwardsVolume:
10
Year:
2007
Language:
english
DOI:
10.1016/s1098-3015(10)65421-6
File:
PDF, 92 KB
english, 2007